Australian medical technology company, Global Kinetics Corporation, is proud to be working with neurologist and Parkinson’s UK-funded researcher, Dr Alastair Noyce from the Institute of Neurology, University College London, to help spot early warning signs of Parkinson’s.
30 January, 2017
NiCoLA-B, the world’s most advanced drug discovery robot, is teaming up with scientists from Cancer Research UK (CRUK) and the Medical Research Council (MRC), through AstraZeneca’s Open Innovation research collaboration programme. The new robot, which can test up to 300,000 compounds a day, is designed to make drug discovery smarter, faster and cheaper. It can work three times more quickly than previous drug discovery robots and can sense and adapt to the presence of its human workmates. This means it can share their workspace without protective guarding.
23 January, 2017